We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+13.37%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$322M
AUM Growth
+$28.8M
Cap. Flow
-$2.72M
Cap. Flow %
-0.84%
Top 10 Hldgs %
28.37%
Holding
285
New
38
Increased
61
Reduced
112
Closed
38

Top Buys

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$5.66M
2
CGNX icon
Cognex
CGNX
+$5.61M
3
TREX icon
Trex
TREX
+$5.37M
4
UNP icon
Union Pacific
UNP
+$5.15M
5
ROK icon
Rockwell Automation
ROK
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Healthcare 17.99%
3 Financials 12.48%
4 Industrials 10.79%
5 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPB icon
251
Campbell Soup
CPB
$6.69B
-98,825
Closed -$4.78M
CVS icon
252
CVS Health
CVS
$122B
-335
Closed -$20K
EFX icon
253
Equifax
EFX
$21.3B
-2,718
Closed -$426K
EWQ icon
254
iShares MSCI France ETF
EWQ
$334M
-7,529
Closed -$210K
EXPO icon
255
Exponent
EXPO
$3.21B
-1,856
Closed -$134K
F icon
256
Ford
F
$55.8B
-282
Closed -$2K
FFIV icon
257
F5
FFIV
$23.2B
-2,123
Closed -$261K
FIS icon
258
Fidelity National Information Services
FIS
$21.9B
-33,969
Closed -$5M
FSS icon
259
Federal Signal
FSS
$7.74B
-5,270
Closed -$154K
FTNT icon
260
Fortinet
FTNT
$120B
-9,675
Closed -$228K
INGR icon
261
Ingredion
INGR
$6.53B
-2,425
Closed -$184K
JNJ icon
262
Johnson & Johnson
JNJ
$631B
-3
Closed
K
263
DELISTED
Kellanova
K
-5,751
Closed -$349K
KMB icon
264
Kimberly-Clark
KMB
$35.9B
-41,660
Closed -$6.15M
LDOS icon
265
Leidos
LDOS
$17.5B
-3,050
Closed -$272K
LMT icon
266
Lockheed Martin
LMT
$139B
-13,893
Closed -$5.33M
LXP icon
267
LXP Industrial Trust
LXP
$3.58B
-3,177
Closed -$166K
MDLZ icon
268
Mondelez International
MDLZ
$78.5B
-85,433
Closed -$4.91M
MU icon
269
Micron Technology
MU
$972B
-86,170
Closed -$4.05M
NBIX icon
270
Neurocrine Biosciences
NBIX
$16.8B
-1,273
Closed -$122K
NKTR icon
271
Nektar Therapeutics
NKTR
$2.53B
-472
Closed -$117K
PETS icon
272
PetMed Express
PETS
$42.1M
-4,760
Closed -$151K
PRGO icon
273
Perrigo
PRGO
$1.75B
-9,816
Closed -$451K
SAP icon
274
SAP
SAP
$241B
-376
Closed -$59K
TAK icon
275
Takeda Pharmaceutical
TAK
$56B
-1,458
Closed -$26K

Similar funds

Contravisory Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Contravisory Investment Management held 285 positions worth $322M, up 9.8% from $293M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Contravisory Investment Management's Q4 2020 filing shows 38 new, 61 increased, 112 reduced and 38 closed positions. Its largest new stake was Cognex: 77,192 shares worth $6.2M. The largest sale was AbbVie, an estimated $6.39M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Contravisory Investment Management's largest Q4 2020 buy was Cognex: 77,192 shares worth $6.2M.
  • Contravisory Investment Management added most to Autodesk in Q4 2020, an estimated $5.66M increase.
  • Contravisory Investment Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $6.39M.
  • Contravisory Investment Management fully exited Kimberly-Clark in Q4 2020, selling an estimated $6.15M.
  • Contravisory Investment Management's ten largest holdings make up 28% of its $322M portfolio in Q4 2020.
  • Contravisory Investment Management opened 38 new positions and closed 38 in Q4 2020.
  • Contravisory Investment Management's portfolio value rose 9.8% quarter-over-quarter to $322M.

Based on Contravisory Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.